𝔖 Bobbio Scriptorium
✦   LIBER   ✦

O-245 Randomized phase II clinical trial of cetuximab in combination with cisplatin and vinorelbine or cisplatin and vinorelbine alone in patients (pts) with advanced epidermal growth factor receptor (EGFR)-positive non-small-cell lung cancer (NSCLC)

✍ Scribed by Rosell, Rafael; Constenla, Manuel; Kolb, Rainer; Pfeiffer, Wolfang; O'Bryne, Ken; Pirker, Robert; Montaner, Isil; Jiménez, Enrique; Mueser, Matthias; Gatzemeier, Ulrich


Book ID
118571635
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
178 KB
Volume
41
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES